Practices

Cases Investigated

Beasley Allen is currently investigating cases involving over-the-counter drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Ovarian cancer patients appeal ruling in J&J talc lawsuits in New Jersey

January 31, 2017 - Attorneys for two women battling ovarian cancer have filed an appeal in the Superior Court of New Jersey, arguing that a trial judge erred when he excluded expert testimony about links... Read More


Missouri Supreme Court denies requests to delay talc-related cancer trials

January 26, 2017 - The Missouri Supreme Court has denied requests by Johnson & Johnson (NYSE:JNJ) and its supplier of baby powder talc to delay upcoming trials over allegations that the company's talc-based... Read More


Missouri court denies J&J request to delay talc-related cancer trials

January 5, 2017 - The Missouri Court of Appeals has denied a request by Johnson & Johnson to delay upcoming trials of ovarian cancer claims brought by individuals and families who allege that use of the... Read More


Beasley Allen appointed to leadership role in Johnson & Johnson talc MDL

December 6, 2016 - Leigh O’Dell, Beasley Allen Principal, will serve as Co-Lead Counsel for multidistrict litigation (MDL) involving the Johnson & Johnson talc litigation consolidated in Trenton, N.J. Read More


Jury finds Johnson & Johnson, Imerys liable for $70 million in third ovarian cancer talc trial

October 27, 2016 - A third St. Louis jury has found Johnson & Johnson liable for ovarian cancer linked to talcum powder in its Johnson’s Baby Powder and Shower to Shower products. Talc supplier Imerys also... Read More


Jere Beasley challenges J&J to release all talc documents, trial transcripts

August 25, 2016 - Announcing its appeal of two multimillion-dollar verdicts linking talc to ovarian cancer, Johnson & Johnson claims plaintiff lawyers created confusion about the link, while denying its own... Read More


Possible serious side effects of PPI heartburn drugs include increased risk of kidney disease

June 29, 2016 - The research looked at the treatment of nearly 200,000 patients for more than five years and found approximately 20 percent higher risk of kidney disease in PPI users. Read More


Jere Beasley calls for Johnson & Johnson to end talc litigation

May 5, 2016 - Following another jury verdict finding Johnson & Johnson liable for ovarian cancer related to its talc products, Jere Beasley calls on the company to end talc litigation, pull talc products... Read More


Johnson & Johnson hit with second verdict linking talc products to ovarian cancer

May 2, 2016 - A Missouri state jury awarded Plaintiff Gloria Ristesund $55 million, finding J&J talcum powder products liable for her ovarian cancer. The verdict includes $5 million in actual damages and... Read More


Physician shares science of talcum powder link to ovarian cancer risk ahead of next scheduled trials

March 7, 2016 - Dr. Daniel Cramer has explained talcum powder link to ovarian cancer; discusses research as trial calendar for additional talc cases moves forward. Read More


back to top